Wearable silent speech technology to enhance impaired oral communication
Wearable silent speech technology to enhance impaired oral communication
批准号:
10669628
负责人:
Jun Wang
金额:
$57.25万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-15 至 2024-07-31
关键词:
AcousticsAgeAlaryngeal SpeechAlgorithmsArticular Range of MotionArticulationArticulatorsCharacteristicsCommunicationDataData CollectionDevelopmentDevicesElectrolarynxElectromagneticsEnhancement TechnologyEsophageal SpeechExcisionGenderGoalsHealthHoarsenessHumanImpairmentIndividualKnowledgeLaryngeal ProsthesisLaryngectomeeLaryngectomyLarynxLifeLip structureMachine LearningMagnetismMalignant neoplasm of larynxMapsMeasuresMechanicsMental DepressionMotionMotorMovementOutputParticipantPatientsPatternPerformancePersonsPopulationPositioning AttributeProductionQuality of lifeResearchRoboticsScienceSelf-Help DevicesShapesSpeechSpeech DisordersSpeech SoundSpeech SynthesizersSpeech TherapySpeedTechnologyTestingTimeTongueTracerTracheoesophageal SpeechUnited StatesVoiceVoice DisordersVoice QualityWireless Technologyalternative communicationauditory feedbackdesignefficacy evaluationexperimental studyimprovedinnovationkinematicslanguage trainingmachine learning algorithmmagnetic devicesmillisecondnew technologynoveloral communicationpreservationprototypesocialsocial exclusionsoundspeech synthesistoolvibrationvisual feedbackvocal cordvocalizationwearable devicewirelesswireless electronic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
The long-term objectives of this project are to obtain a deeper understanding how articulatory movement
patterns are mapped to speech particularly when there is no vocal fold vibration (silent speech) and then to
develop a novel, wearable assistive technology called silent speech interface (SSI) to assist the impaired oral
communication for individuals in need (e.g., individuals after laryngectomy, surgical removal of larynx to treat
advanced laryngeal cancer). Designed for daily use, the SSI contains a wearable magnetic device and a small
camera for tongue and lip motion tracking, respectively, and an articulation-to-speech synthesizer to output
natural sounding speech that preserves the speaker’s voice characteristics. Specific Aims of the proposal
include to (1) determine the articulatory patterns of normal (vocalized) and silent speech, produced by both
healthy talkers and people after laryngectomy, (2) develop a wearable, wireless magnetic device for real-time
tongue and lip motion tracking, and (3) synthesize speech from articulation directly.
There are currently limited alternative communication options for people who have undergone laryngectomy.
These options include esophageal speech, tracheo-esophageal speech, and use of an artificial larynx (or
electrolarynx). These solutions are either invasive or difficult to use, and all of them result in a hoarse or
mechanical/robotic sounding voice, which can be difficult to understand. In contrast, the SSI in this application
is non-invasive, easy-to-use, and produces natural sounding speech and may even preserve the patient’s
voice identity. We have exciting preliminary results that support the feasibility of the project including that (1)
we have recently developed a wireless magnetic device for tongue motion, and (2) we have demonstrated real-
time articulation-to-speech synthesis with a 90% word accuracy (judged by a human listener). In this project,
we will further reduce the size of the wireless device and make it wearable and conduct articulation-to-speech
algorithms by studying 30 participants after laryngectomy and 30 age- and gender-matched healthy controls. If
successful, the proposed research will enhance human health by making an impact on individuals after
laryngectomy and potentially to a broader range of other speech and voice disorders. In addition, the
technology will have an impact to the speech science field by providing a fist-time-ever tool for potential large-
scale tongue motion data collection and have a variety of broader implications including visual feedback-based
secondary language training and speech therapy, which may benefit millions of people with motor speech
deficits in the United States.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3390/s22166056
发表时间:
2022-08-13
期刊:
Sensors (Basel, Switzerland)
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1109/jsen.2020.3046469
发表时间:
2021-03-15
期刊:
IEEE sensors journal
影响因子:
4.3
作者:
[Sebkhi N, Bhavsar A, Anderson DV, Wang J, Inan OT]
通讯作者:
Inan OT
Voice Onset Time in Early- and Late-Stage Amyotrophic Lateral Sclerosis.
早期和晚期肌萎缩侧索硬化症的发声时间。
DOI:
10.1044/2022_jslhr-21-00632
发表时间:
2022
期刊:
Journal of speech, language, and hearing research : JSLHR
影响因子:
--
作者:
[Thomas,Anusha, Teplansky,KristinJ, Wisler,Alan, Heitzman,Daragh, Austin,Sara, Wang,Jun]
通讯作者:
Wang,Jun
MagTrack: A Wearable Tongue Motion Tracking System for Silent Speech Interfaces.
MagTrack:用于无声语音接口的可穿戴舌头运动跟踪系统。
DOI:
10.1044/2023_jslhr-22-00319
发表时间:
2023
期刊:
Journal of speech, language, and hearing research : JSLHR
影响因子:
--
作者:
[Cao,Beiming, Ravi,Shravan, Sebkhi,Nordine, Bhavsar,Arpan, Inan,OmerT, Xu,Wen, Wang,Jun]
通讯作者:
Wang,Jun
Striatal ensemble plasticity in alcohol use disorder
-
批准号:10734890
-
项目类别:
-
资助金额:$45.81万
-
财政年份:2023
-
负责人:Jun Wang
-
依托单位:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10457835
-
项目类别:
-
资助金额:$74.14万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
High-Resolution Spatial MIST Technology for Functional Proteomic Study of Neuroinflammation in Alzheimer's Disease
-
批准号:10343115
-
项目类别:
-
资助金额:$46.25万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Repurposing of Maraviroc for the treatment of neuropathic pain
-
批准号:10586296
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Sex-specific role of CCL5/CCR5 axis in depression and its therapeutic implication
-
批准号:10364861
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
NanoDiagnotic Technology I-Corps Training
-
批准号:10541690
-
项目类别:
-
资助金额:$5.5万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10543633
-
项目类别:
-
资助金额:$39.27万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10693823
-
项目类别:
-
资助金额:$73.01万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Sex-specific role of CCL5/CCR5 axis in depression and its therapeutic implication
-
批准号:10653682
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Rapid detection of infectious viral particles by cluster induced exhaustive reaction
-
批准号:10443877
-
项目类别:
-
资助金额:$23.59万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10191875
-
项目类别:
-
资助金额:$27.83万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Rapid detection of infectious viral particles by cluster induced exhaustive reaction
-
批准号:10282122
-
项目类别:
-
资助金额:$19.6万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Development of an integrated smartphone/resistive nanosensor for onsite biomonitoring of exposure to pesticides
-
批准号:10255622
-
项目类别:
-
资助金额:$25.59万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Single-Cell Functional Proteomics Study of Neurodegeneration in Alzheimer's Disease
-
批准号:10191268
-
项目类别:
-
资助金额:$43.86万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Ethanol drinking and the basal ganglia circuitry
-
批准号:10599264
-
项目类别:
-
资助金额:$33.33万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Ethanol drinking and the basal ganglia circuitry
-
批准号:10513411
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Genetic dissection of Cardiac Conduction System homeostasis and regeneration
-
批准号:9740018
-
项目类别:
-
资助金额:$36.62万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Ethanol drinking and the basal ganglia circuitry
-
批准号:10190746
-
项目类别:
-
资助金额:$33.4万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Drug target validation of the enterovirus D68 2A protease
-
批准号:10543627
-
项目类别:
-
资助金额:$54.06万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Drug target validation of the enterovirus D68 2A protease
-
批准号:10454230
-
项目类别:
-
资助金额:$72.07万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: